title: Generic vs. proprietary otic drops.
authors.forename: W F
authors.initials: WF
authors.lastname: Hotmes
authors.forename: J D
authors.initials: JD
authors.lastname: Cunningham
authors.forename: E
authors.initials: E
authors.lastname: Alford
mesh_terms: D004338:Drug Combinations / Q000009:adverse effects; D004427:Ear Diseases / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects*; D006863:Hydrogen-Ion Concentration; D009355:Neomycin / Q000009:adverse effects*; D011112:Polymyxin B / Q000009:adverse effects*; D011113:Polymyxins / Q000009:adverse effects*; D013810:Therapeutic Equivalency; D014432:Tympanic Membrane
chemical_list: D004338:Drug Combinations; D011113:Polymyxins; C033225:hydrocortisone, neomycin, polymyxin B drug combination; D009355:Neomycin; D011112:Polymyxin B; D006854:Hydrocortisone